Jim Cramer says it's too soon to tell how GLP-1 weight loss drugs will affect food stocks

CNBC's Jim Cramer on Tuesday said it may be too soon to tell how GLP-1 diabetes and weight loss drugs will change companies, especially ones that sell junk food.on Tuesday said it may be too soon to tell how GLP-1 diabetes and weight loss drugs will affect the stock of companies like

Walmart said last week it is seeing a"slight change" in food-shopping habits, some of which may be due to customers buying less while using appetite-suppressing medications like diabetes drugs Mounjaro or Wegovy,

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Jim Cramer's top 10 things to watch in the stock market MondayThe Dow, S&P 500 and Nasdaq were lower Monday after Hamas conducted a surprise attack on Israel.
Источник: CNBC - 🏆 12. / 72 Прочитайте больше »

Jim Cramer's top 10 things to watch in the stock market TuesdayWall Street stabilizes: The Dow, the S&P 500 and the Nasdaq little changed early Tuesday.
Источник: CNBC - 🏆 12. / 72 Прочитайте больше »

Jim Cramer explains why the Israel-Hamas war may not steer Monday's market actionCNBC’s Jim Cramer suggested the deadly conflict between Israel and Hamas may not be the driving force in Monday’s market action.
Источник: NBCDFW - 🏆 288. / 63 Прочитайте больше »

Jim Cramer sees a bull market in cybersecurityCNBC’s Jim Cramer said demand for cybersecurity is high, indicating a potential bull market for the sector.
Источник: nbcchicago - 🏆 545. / 51 Прочитайте больше »